Mitochondrial HEP27 is a c-Myb target gene that inhibits Mdm2 and stabilizes p53

Molecular and Cellular Biology

Volumn 30, Issue 16, 2010, Pages 3981-3993

  Deisenroth, Chad ^a,b   Thorner, Aaron R ^a,b   Enomoto, Takeharu ^c   Perou, Charles M ^b   Zhang, Yanping ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; MITOCHONDRIAL PROTEIN; PROTEIN HEP27; PROTEIN MDM2; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELLULAR STRESS RESPONSE; CELLULAR STRESS SIGNAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA REPAIR; HEP27 GENE; HUMAN; HUMAN CELL; MITOCHONDRION; ONCOGENE; ONCOGENE C MYB; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSMISSION ELECTRON MICROSCOPY;

ALCOHOL OXIDOREDUCTASES; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; CELL NUCLEUS; FEMALE; GENES, MYB; HUMANS; MICROSCOPY, IMMUNOELECTRON; MITOCHONDRIA; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN STABILITY; PROTO-ONCOGENE PROTEINS C-MDM2; RECEPTORS, ESTROGEN; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77955602643     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01284-09     Document Type: Article

References (63)

1. Becker, K. A., S. Lu, E. S. Dickinson, K. A. Dunphy, L. Mathews, S. S. Schneider, and D. J. Jerry. 2005. Estrogen and progesterone regulate radiation- induced p53 activity in mammary epithelium through TGF-beta-dependent pathways. Oncogene 24:6345-6353.
2. Berge, T., V. Matre, E. M. Brendeford, T. Saether, B. Luscher, and O. S. Gabrielsen. 2007. Revisiting a selection of target genes for the hematopoietic transcription factor c-Myb using chromatin immunoprecipitation and c-Myb knockdown. Blood Cells Mol. Dis. 39:278-286.
3. Bjorkqvist, A. M., M. Wolf, S. Nordling, L. Tammilehto, A. Knuuttila, J. Kere, K. Mattson, and S. Knuutila. 1999. Deletions at 14q in malignant mesothelioma detected by microsatellite marker analysis. Br. J. Cancer 81:1111-1115.
4. Cheng, Y., J. M. Ko, H. L. Lung, P. H. Lo, E. J. Stanbridge, and M. L. Lung. 2003. Monochromosome transfer provides functional evidence for growth-suppressive genes on chromosome 14 in nasopharyngeal carcinoma. Genes Chromosomes Cancer 37:359-368. (Pubitemid 36775778)
5. Claros, M. G., and P. Vincens. 1996. Computational method to predict mitochondrially imported proteins and their targeting sequences. Eur. J. Biochem. 241:779-786.
6. Dai, M. S., and H. Lu. 2004. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J. Biol. Chem. 279:44475-44482.
7. Debiec-Rychter, M., R. Sciot, P. Pauwels, E. Schoenmakers, P. Dal Cin, and A. Hagemeijer. 2001. Molecular cytogenetic definition of three distinct chromosome arm 14q deletion intervals in gastrointestinal stromal tumors. Genes Chromosomes Cancer 32:26-32. (Pubitemid 32737781)
8. Donadel, G., C. Garzelli, R. Frank, and F. Gabrielli. 1991. Identification of a novel nuclear protein synthesized in growth-arrested human hepatoblastoma HepG2 cells. Eur. J. Biochem. 195:723-729.
9. Drabsch, Y., H. Hugo, R. Zhang, D. H. Dowhan, Y. R. Miao, A. M. Gewirtz, S. C. Barry, R. G. Ramsay, and T. J. Gonda. 2007. Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 104:13762-13767.
10. El-Rifai, W., M. Sarlomo-Rikala, L. C. Andersson, M. Miettinen, and S. Knuutila. 2000. High-resolution deletion mapping of chromosome 14 in stromal tumors of the gastrointestinal tract suggests two distinct tumor suppressor loci. Genes Chromosomes Cancer 27:387-391. (Pubitemid 30127627)
11. Emanuelsson, O., H. Nielsen, S. Brunak, and G. von Heijne. 2000. Predicting subcellular localization of proteins based on their N-terminal amino acid sequence. J. Mol. Biol. 300:1005-1016.
12. Gabrielli, F., G. Donadel, G. Bensi, A. Heguy, and M. Melli. 1995. A nuclear-protein, synthesized in growth-arrested human hepatoblastoma cells, is a novel member of the short-chain alcohol-dehydrogenase family. Eur. J. Biochem. 232:473-477.
13. Goeze, A., K. Schluns, G. Wolf, Z. Thasler, S. Petersen, and I. Petersen. 2002. Chromosomal imbalances of primary and metastatic lung adenocarcinomas. J. Pathol. 196:8-16.
14. Goldenthal, M. J., and J. Marin-Garcia. 2004. Mitochondrial signaling pathways: a receiver/integrator organelle. Mol. Cell. Biochem. 262:1-16.
15. Gonda, T. J. 1998. The c-Myb oncoprotein. Int. J. Biochem. Cell Biol. 30:547-551.
16. Hawkins, J., D. Mahony, S. Maetschke, M. Wakabayashi, R. D. Teasdale, and M. Boden. 2007. Identifying novel peroxisomal proteins. Proteins 69:606-616.
17. Herschkowitz, J. I., et al. 2007. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol. 8:R76.
18. Hurd, C., N. Khattree, P. Alban, K. Nag, S. C. Jhanwar, S. Dinda, and V. K. Moudgil. 1995. Hormonal regulation of the p53 tumor suppressor protein in T47D human breast carcinoma cell line. J. Biol. Chem. 270:28507-28510.
19. Jin, A., K. Itahana, K. O'Keefe, and Y. Zhang. 2004. Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol. Cell. Biol. 24:7669-7680.
20. Jornvall, H., B. Persson, M. Krook, S. Atrian, R. Gonzalez-Duarte, J. Jeffery, and D. Ghosh. 1995. Short-chain dehydrogenases/reductases (SDR). Biochemistry 34:6003-6013.
21. Khan, I. U., R. Wallin, R. S. Gupta, and G. M. Kammer. 1998. Protein kinase A-catalyzed phosphorylation of heat shock protein 60 chaperone regulates its attachment to histone 2B in the T lymphocyte plasma membrane. Proc. Natl. Acad. Sci. U. S. A. 95:10425-10430.
22. Kuperwasser, C., J. Pinkas, G. D. Hurlbut, S. P. Naber, and D. J. Jerry. 2000. Cytoplasmic sequestration and functional repression of p53 in the mammary epithelium is reversed by hormonal treatment. Cancer Res. 60:2723-2729. (Pubitemid 30318250)
23. Lei, W. L., J. J. Rushton, L. M. Davis, F. Liu, and S. A. Ness. 2004. Positive and negative determinants of target gene specificity in Myb transcription factors. J. Biol. Chem. 279:29519-29527.
24. Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
25. Liu, F., W. Lei, J. P. O'Rourke, and S. A. Ness. 2006. Oncogenic mutations cause dramatic, qualitative changes in the transcriptional activity of c-Myb. Oncogene 25:795-805. (Pubitemid 43214705)
26. Lohrum, M. A., R. L. Ludwig, M. H. Kubbutat, M. Hanlon, and K. H. Vousden. 2003. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 3:577-587. (Pubitemid 36808652)
27. Maya, R., M. Balass, S. T. Kim, D. Shkedy, J. F. Leal, O. Shifman, M. Moas, T. Buschmann, Z. Ronai, Y. Shiloh, M. B. Kastan, E. Katzir, and M. Oren. 2001. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev. 15:1067-1077.
28. Mayo, L. D., J. J. Turchi, and S. J. Berberich. 1997. Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53. Cancer Res. 57:5013-5016. (Pubitemid 27498111)
29. Miller, L. D., J. Smeds, J. George, V. B. Vega, L. Vergara, A. Ploner, Y. Pawitan, P. Hall, S. Klaar, E. T. Liu, and J. Bergh. 2005. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc. Natl. Acad. Sci. U. S. A. 102:13550-13555.
30. Mutirangura, A., W. Pornthanakasem, V. Sriuranpong, P. Supiyaphun, and N. Voravud. 1998. Loss of heterozygosity on chromosome 14 in nasopharyngeal carcinoma. Int. J. Cancer. 78:153-156.
31. Ness, S. A. 1996. The Myb oncoprotein: regulating a regulator. Biochim. Biophys. Acta 1288:F123-F139.
32. Ness, S. A. 2003. Myb protein specificity: evidence of a context-specific transcription factor code. Blood Cells Mol. Dis. 31:192-200.
33. Neuspiel, M., A. C. Schauss, E. Braschi, R. Zunino, P. Rippstein, R. A. Rachubinski, M. A. Andrade-Navarro, and H. M. McBride. 2008. Cargo-selected transport from the mitochondria to peroxisomes is mediated by vesicular carriers. Curr. Biol. 18:102-108.
34. Oh, I. H., and E. P. Reddy. 1999. The myb gene family in cell growth, differentiation and apoptosis. Oncogene 18:3017-3033.
35. Pagliarini, D. J., S. E. Calvo, B. Chang, S. A. Sheth, S. B. Vafai, S. E. Ong, G. A. Walford, C. Sugiana, A. Boneh, W. K. Chen, D. E. Hill, M. Vidal, J. G. Evans, D. R. Thorburn, S. A. Carr, and V. K. Mootha. 2008. A mitochondrial protein compendium elucidates complex I disease biology. Cell 134:112-123.
36. Parker, J. S., M. Mullins, M. C. Cheang, S. Leung, D. Voduc, T. Vickery, S. Davies, C. Fauron, X. He, Z. Hu, J. F. Quackenbush, I. J. Stijleman, J. Palazzo, J. S. Marron, A. B. Nobel, E. Mardis, T. O. Nielsen, M. J. Ellis, C. M. Perou, and P. S. Bernard. 2009. Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol. 27:1160-1167.
37. Pellegrini, S., S. Censini, S. Guidotti, P. Iacopetti, M. Rocchi, M. Bianchi, A. Covacci, and F. Gabrielli. 2002. A human short-chain dehydrogenase/reductase gene: structure, chromosomal localization, tissue expression and subcellular localization of its product. Biochem. Biophys. Acta Gene Struct. Expr. 1574:215-222.
38. Petropavlovskaia, M., C. A. Bodnar, L. A. Behie, and L. Rosenberg. 2006. Pancreatic small cells: analysis of quiescence, long-term maintenance and insulin expression in vitro. Exp. Cell Res. 30:30.
39. Pfanner, N. 2000. Protein sorting: recognizing mitochondrial presequences. Curr. Biol. 10:R412-R415.
40. Ramsay, R. G. 2005. c-Myb a stem-progenitor cell regulator in multiple tissue compartments. Growth Factors 23:253-261.
41. Ramsay, R. G., and T. J. Gonda. 2008. MYB function in normal and cancer cells. Nat. Rev. Cancer 8:523-534.
42. Ramsby, M. L., and G. S. Makowski. 1999. Differential detergent fractionation of eukaryotic cells. Analysis by two-dimensional gel electrophoresis. Methods Mol. Biol. 112:53-66.
43. Rouzier, R., C. M. Perou, W. F. Symmans, N. Ibrahim, M. Cristofanilli, K. Anderson, K. R. Hess, J. Stec, M. Ayers, P. Wagner, P. Morandi, C. Fan, I. Rabiul, J. S. Ross, G. N. Hortobagyi, and L. Pusztai. 2005. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin. Cancer Res. 11:5678-5685.
44. Rushton, J. J., L. M. Davis, W. Lei, X. Mo, A. Leutz, and S. A. Ness. 2003. Distinct changes in gene expression induced by A-Myb, B-Myb and c-Myb proteins. Oncogene 22:308-313.
45. Ryan, M. T., and N. J. Hoogenraad. 2007. Mitochondrial-nuclear communications. Annu. Rev. Biochem. 76:701-722.
46. Saji, S., S. Nakashima, S. Hayashi, M. Toi, and Y. Nozawa. 1999. Overexpression of MDM2 in MCF-7 promotes both growth advantage and p53 accumulation in response to estradiol. Jpn. J. Cancer Res. 90:210-218.
47. Shafqat, N., J. Shafqat, G. Eissner, H. U. Marschall, K. Tryggvason, U. Eriksson, F. Gabrielli, H. Lardy, H. Jornvall, and U. Oppermann. 2006. Hep27, a member of the short-chain dehydrogenase/reductase family, is an NADPH-dependent dicarbonyl reductase expressed in vascular endothelial tissue. Cell. Mol. Life Sci. 63:1205-1213.
48. Sharpless, N. E., and R. A. DePinho. 1999. The INK4A/ARF locus and its two gene products. Curr. Opin. Genet. Dev. 9:22-30.
49. Sickmann, A., J. Reinders, Y. Wagner, C. Joppich, R. Zahedi, H. E. Meyer, B. Schonfisch, I. Perschil, A. Chacinska, B. Guiard, P. Rehling, N. Pfanner, and C. Meisinger. 2003. The proteome of Saccharomyces cerevisiae mitochondria. Proc. Natl. Acad. Sci. U. S. A. 100:13207-13212.
50. Sivaraman, L., O. M. Conneely, D. Medina, and B. W. O'Malley. 2001. p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis. Proc. Natl. Acad. Sci. U. S. A. 98:12379-12384.
51. Soltys, B. J., and R. S. Gupta. 1996. Immunoelectron microscopic localization of the 60-kDa heat shock chaperonin protein (Hsp60) in mammalian cells. Exp. Cell Res. 222:16-27.
52. Soltys, B. J., and R. S. Gupta. 1999. Mitochondrial-matrix proteins at unexpected locations: are they exported? Trends Biochem. Sci. 24:174-177.
53. Sorlie, T., C. M. Perou, C. Fan, S. Geisler, T. Aas, A. Nobel, G. Anker, L. A. Akslen, D. Botstein, A. L. Borresen-Dale, and P. E. Lonning. 2006. Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer. Mol. Cancer Ther. 5:2914-2918.
54. Sorlie, T., R. Tibshirani, J. Parker, T. Hastie, J. S. Marron, A. Nobel, S. Deng, H. Johnsen, R. Pesich, S. Geisler, J. Demeter, C. M. Perou, P. E. Lonning, P. O. Brown, A. L. Borresen-Dale, and D. Botstein. 2003. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. U. S. A. 100:8418-8423.
55. Tanikawa, J., E. Ichikawa-Iwata, C. Kanei-Ishii, and S. Ishii. 2001. Regulation of c-Myb activity by tumor suppressor p53. Blood Cells Mol. Dis. 27:479-482.
56. Tanikawa, J., T. Nomura, E. M. Macmillan, T. Shinagawa, W. Jin, K. Kokura, D. Baba, M. Shirakawa, T. J. Gonda, and S. Ishii. 2004. p53 suppresses c-Myb-induced trans-activation and transformation by recruiting the corepressor mSin3A. J. Biol. Chem. 279:55393-55400.
57. Troester, M. A., J. I. Herschkowitz, D. S. Oh, X. He, K. A. Hoadley, C. S. Barbier, and C. M. Perou. 2006. Gene expression patterns associated with p53 status in breast cancer. BMC Cancer 6:276.
58. Truscott, K. N., K. Brandner, and N. Pfanner. 2003. Mechanisms of protein import into mitochondria. Curr. Biol. 13:R326-R337.
59. van de Vijver, M. J., et al. 2002. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347:1999-2009.
60. Wadhwa, R., S. C. Kaul, Y. Ikawa, and Y. Sugimoto. 1993. Identification of a novel member of mouse hsp70 family. Its association with cellular mortal phenotype. J. Biol. Chem. 268:6615-6621.
61. Yi, H., J. Leunissen, G. Shi, C. Gutekunst, and S. Hersch. 2001. A novel procedure for pre-embedding double immunogold-silver labeling at the ultrastructural level. J. Histochem. Cytochem. 49:279-284.
62. Yu, C. L., P. Driggers, G. Barrera-Hernandez, S. B. Nunez, J. H. Segars, and S. Cheng. 1997. The tumor suppressor p53 is a negative regulator of estrogen receptor signaling pathways. Biochem. Biophys. Res. Commun. 239:617-620.
63. Zhang, Y. P., G. W. Wolf, K. Bhat, A. Jin, T. Allio, W. A. Burkhart, and Y. Xiong. 2003. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol. Cell Biol. 23:8902-8912.